First Trust Advisors LP raised its position in athenahealth, Inc (NASDAQ:ATHN) by 3.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 118,271 shares of the health services provider’s stock after buying an additional 4,356 shares during the quarter. First Trust Advisors LP owned 0.29% of athenahealth worth $15,801,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Integrated Investment Consultants LLC acquired a new stake in shares of athenahealth during the 2nd quarter worth $150,000. Ropes Wealth Advisors LLC acquired a new stake in shares of athenahealth during the 2nd quarter worth $194,000. Campbell & CO Investment Adviser LLC acquired a new stake in shares of athenahealth during the 2nd quarter worth $206,000. Strs Ohio acquired a new stake in shares of athenahealth during the 2nd quarter worth $208,000. Finally, Hengehold Capital Management LLC acquired a new stake in shares of athenahealth during the 2nd quarter worth $214,000.
Shares of ATHN stock opened at $120.35 on Friday. The company has a quick ratio of 2.62, a current ratio of 2.62 and a debt-to-equity ratio of 0.23. athenahealth, Inc has a twelve month low of $116.77 and a twelve month high of $163.94. The firm has a market cap of $5.12 billion, a P/E ratio of 39.74, a price-to-earnings-growth ratio of 2.23 and a beta of 0.80.
In related news, insider Daniel P. Haley sold 2,204 shares of the company’s stock in a transaction on Monday, October 1st. The stock was sold at an average price of $127.23, for a total transaction of $280,414.92. Following the completion of the sale, the insider now directly owns 10,555 shares in the company, valued at approximately $1,342,912.65. The sale was disclosed in a filing with the SEC, which is available through this link. Over the last 90 days, insiders have sold 2,654 shares of company stock valued at $340,770. 2.90% of the stock is owned by corporate insiders.
Several analysts have recently issued reports on the company. Cowen reissued a “hold” rating and set a $150.00 target price on shares of athenahealth in a report on Wednesday, August 1st. Stifel Nicolaus reissued a “hold” rating and set a $140.00 target price (up from $134.00) on shares of athenahealth in a report on Tuesday, July 31st. Cantor Fitzgerald reissued a “hold” rating and set a $145.00 target price on shares of athenahealth in a report on Tuesday, September 18th. Canaccord Genuity increased their target price on athenahealth from $125.00 to $160.00 and gave the stock a “hold” rating in a report on Tuesday, July 31st. Finally, Leerink Swann set a $140.00 target price on athenahealth and gave the stock a “buy” rating in a report on Friday, September 28th. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $153.79.
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Featured Story: How to Invest in Marijuana Stocks
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.